76N.TERT.V
2
76N.TERT.V 76N.TERT.Ecd IgG Ecd antibody MEF. Ecd+/+ upplementary Fig. 1 β-actin 76N.TERT.V 76N.TERT.Ecd hEcd β-actin mEcd MEF mEcd+/+ MEF mEcd-/- IgG Ecd antibody a c MEF.Ecd-/- b d
description
Supplementary Fig. 1. 76N.TERT.Ecd. 76N.TERT.V. a. MEF. Ecd +/+. c. MEF.Ecd -/-. IgG. IgG. Ecd antibody. Ecd antibody. MEF mEcd +/+. 76N.TERT.V. 76N.TERT.Ecd. b. d. MEF mEcd -/-. hEcd. mEcd. β- actin. β- actin. - PowerPoint PPT Presentation
Transcript of 76N.TERT.V
76N
.TE
RT
.V
76N
.TE
RT
.Ecd
IgG
Ecd antibody
ME
F. E
cd+
/+
Supplementary Fig. 1
β-actin
76N
.TE
RT
.V
76N
.TE
RT
.Ecd
hEcd
β-actin
mEcd M
EF
mE
cd+
/+
ME
F m
Ecd
-/-
IgG
Ecd antibody
a c
ME
F.E
cd-/
-
b d
Supplementary Fig.1 Characterization of Ecd antibody specificity for IHC staining. (A). 76NTERT cells expressing either vector (76NTERT.V) or Ecd (76NTERT.Ecd) were analyzed by IHC staining using either mouse IgG (as control) or anti-Ecd antibodies (B) Western blot analysis of cells used in Fig. A (C). IHC staining of mouse embryonic fibroblasts expressing wild type Ecd (Ecd+/+) or cre-adenovirus infected MEFs where Ecd was deleted (Ecd-/-). Mouse IgG was used as negative control. (D) Western blotting of cells used in Figure C.
